Business
Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company
Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n\n \n This Board Appointment Represents the First of Several Others to Soon be Announced TORONTO, ON, Jan. 10, 2018 (GLOBE NEWSWIRE) --  Easton Pharmaceuticals Inc. (OTC PINK: EAPH) is pleased to announce the appointment of Mr. Luigi Gentile as Director to the company with official position and title to be announced alongside other additional board appointments within the next 2 to 3 weeks. Luigi brings to Easton Pharmaceuticals a broad history of commercial leadership and innovation experience leading sales, marketing, product management and R&D teams in Healthcare. He has led several commercial leadership roles at start-ups, SMEs and large multinationals including GE Healthcare.  There he held several positions, most recently Client Solutions Director, leading large strategic initiatives and teams bringing novel solutions to market across Canada.  Prior to that, Luigi was the National Sales and Marketing leader for the GE Healthcare IT business, as well as Executive Director of a global innovation centre successfully brining new pathology modalities to market.  Additionally, Luigi served as VP of Sales and Marketing for Myndtec, launching a new medical device and therapy to markets aimed at helping stroke and spinal cord injury patients recover mobility in paralyzed limbs. He has also previously held the roles of Regional Manager for Olympus Canada’s Scientific Equipment and Medical Imaging Group, as well as the Global Sales and Marketing Leader for EXFO Life Sciences.Before industry, Luigi spent more than 10 years in clinical research and earned a Master’s in Physiology and Collaborative Master’s in Neuroscience from the University of Toronto. Luigi will be assisting Easton with not just Easton’s most recent acquisitions such as Alliance venture partners and Easton’s Mexico, Latin America rollout of its licensed products including from CommonSense of Israel and the subsequent sub-distribution Agreements Easton has entered into as a result of, but will also be an essential and an integral part of asses...